1 Policy The Johnson & Johnson Corporate Signature is a “trust mark” among consumers and other stakeholders. The company’s trust stems from its special connection with consumers created by Overview ® JOHNSON’S Baby, supported by a long-standing commitment to mothers, children and families, and reinforced by responsible and trustworthy business actions. The Corporate Signature Policy guides use of the Johnson & Johnson trust mark. The essence of the policy allows broad use among multiple non-consumer stakeholders by all businesses including Pharmaceutical, Medical Device and Consumer companies. Non-consumer stakeholders are broadly defined as medical professionals, policy makers, hospitals, payers, retailers, etc. Use of the Corporate Signature must be consistent with the appropriate legal entity for our businesses (i.e. Janssen, the Pharmaceutical Companies of Johnson & Johnson). The Corporate Signature is only carefully guarded in broad-scale consumer communication to the general public, with the intent of maintaining the consumer differentiation afforded by our historic global brand equity. This mostly includes consumer packaging, advertising, broad-based digital campaigns and other campaigns targeted to the general public. Specifically, Medical Device, Pharmaceutical and (over-the-counter consumer brands) may not directly use the Johnson & Johnson signature in direct-to-consumer communication. This is the only limitation on use of the Johnson & Johnson Corporate Signature by operating units. Social responsibility and business initiatives reflective of the Johnson & Johnson external agenda use the Corporate Signature. As use is broadened, there is an increasing need to ensure consistent global representation of the Johnson & Johnson brand equity. When communication involves the Corporate Signature, close coordination with the Corporate Signature team is required to ensure a unified global brand image.